ImmunoGen Message Board - Msg: 32465827

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wildbiftek who wrote (5630)	12/17/2019 11:16:08 PM
From: Gary Mohilner	of 5665

I'll agree with what you're saying, but I believe the company still believes that other cancers where patients have high platinum resistance may also benefit from the drug as well. I think there has been some anecdotal applications, but additional trials will be required to prove it. If proven, the potential of the drug could grow dramatically. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next